Ignacio
Íñigo Marco
Investigador hasta 2020
Instituto de Investigación Sanitaria de Navarra
Pamplona, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria de Navarra (5)
2021
-
Delta-24-RGD, an oncolytic adenovirus, increases survival and promotes proinflammatory immune landscape remodeling in models of AT/RT and CNS-PNET
Clinical Cancer Research, Vol. 27, Núm. 6, pp. 1807-1820
-
Imaging of Stroke in Rodents Using a Clinical Scanner and Inductively Coupled Specially Designed Receiver Coils
Annals of Biomedical Engineering, Vol. 49, Núm. 2, pp. 746-756
2020
-
Cb2 receptors and neuron–glia interactions modulate neurotoxicity generated by magl inhibition
Biomolecules, Vol. 10, Núm. 8, pp. 1-15
2019
-
Destress and do not suppress: Targeting adrenergic signaling in tumor immunosuppression
Journal of Clinical Investigation, Vol. 129, Núm. 12, pp. 5086-5088
2017
-
E46K α-synuclein pathological mutation causes cell-autonomous toxicity without altering protein turnover or aggregation
Proceedings of the National Academy of Sciences of the United States of America, Vol. 114, Núm. 39, pp. E8274-E8283